Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Clinical trial NCT02511431 · COMPLETED
Trial details
- NCT number
- NCT02511431
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-29
- Primary completion
- 2017-02-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.